Home > Financial Ratios > TORRENT PHARMACEUTICALS

TORRENT PHARMACEUTICALS
EV/Net Sales

    Back to All Ratios
TORRENT PHARMACEUTICALS is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
COMMUNITY POLL
for TORRENT PHARMACEUTICALS
Please provide your vote to see the results

TORRENT PHARMACEUTICALS Last 5 Year EV/Net Sales History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   EV/Net Sales(x) 8.505.905.995.904.85

What is the latest EV/Net Sales ratio of TORRENT PHARMACEUTICALS ?

The latest EV/Net Sales ratio of TORRENT PHARMACEUTICALS is 8.50 based on Mar2024 Consolidated results.
Year EV/Net Sales
Mar20248.50
Mar20235.90
Mar20225.99
Mar20215.90
Mar20204.85

How is EV/Net Sales of TORRENT PHARMACEUTICALS Trending?

Years EV/Net Sales % Change
Mar2024 8.5
44.07
Mar2023 5.9
-1.50
Mar2022 5.99
1.53
Mar2021 5.9
21.65
Mar2020 4.85 -

Other Financial Ratios of TORRENT PHARMACEUTICALS


Compare EV/Net Sales ratio of peers of TORRENT PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
TORRENT PHARMACEUTICALS ₹112,492.6 Cr 2.1% 2.9% 31.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹432,960.0 Cr 3.1% 3.1% 17.5% Stock Analytics
DIVIS LABORATORIES ₹165,003.0 Cr 10.2% 6.7% 61.3% Stock Analytics
CIPLA ₹125,289.0 Cr 2.4% 2.5% 14% Stock Analytics
MANKIND PHARMA ₹107,386.0 Cr 0.8% 15.9% 9% Stock Analytics
DR REDDYS LABORATORIES ₹100,256.0 Cr 3.2% 1.3% -0.2% Stock Analytics


TORRENT PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
TORRENT PHARMACEUTICALS

2.1%

2.9%

31.4%

SENSEX

3.6%

5.8%

10.1%


You may also like the below Video Courses